glp 1 and diverticulosis GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Weekend Wellness: Will diverticulitis come

Despite the potential clinical benefits of GLP-1RA plus SGLT2i combination therapy in patients with T2DM, several factors may delay this combination to become a common practice soon, such as reimbursement and costs associated with polypharmacy

The China Center for Drug Evaluation (CDE) announced that Shiling Pharma's semaglutide nasal spray has been approved for clinical trials for long-term weight management in adults (obese and overweight)

Personalized treatment, fast approvals, and expert support every week.

CNNs Erin Burnett speaks to Eli Lilly CEO David Ricks on major changes to weight-loss drugs and expanded manufacturing